Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder characterized by difficulties with social interaction, repetitive behavior, and additional features, such as special interests. Its precise etiology is unclear. Recently, immunological mechanisms, such as maternal autoantibodies/...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/10/6/355 |
_version_ | 1827715401067266048 |
---|---|
author | Kimon Runge Ludger Tebartz van Elst Simon Maier Kathrin Nickel Dominik Denzel Miriam Matysik Hanna Kuzior Tilman Robinson Thomas Blank Rick Dersch Katharina Domschke Dominique Endres |
author_facet | Kimon Runge Ludger Tebartz van Elst Simon Maier Kathrin Nickel Dominik Denzel Miriam Matysik Hanna Kuzior Tilman Robinson Thomas Blank Rick Dersch Katharina Domschke Dominique Endres |
author_sort | Kimon Runge |
collection | DOAJ |
description | Autism spectrum disorder (ASD) is a common neurodevelopmental disorder characterized by difficulties with social interaction, repetitive behavior, and additional features, such as special interests. Its precise etiology is unclear. Recently, immunological mechanisms, such as maternal autoantibodies/infections, have increasingly been the subject of discussion. Cerebrospinal fluid (CSF) investigations play a decisive role in the detection of immunological processes in the brain. This study therefore retrospectively analyzed the CSF findings of adult patients with ASD. CSF basic measures (white blood cell count, total protein, albumin quotient, immunoglobulin G (IgG) index, and oligoclonal bands) and various antineuronal antibody findings of 36 adult patients with ASD, who had received lumbar puncture, were compared with an earlier described mentally healthy control group of 39 patients with idiopathic intracranial hypertension. CSF protein concentrations and albumin quotients of patients with ASD were significantly higher as compared to controls (age corrected: <i>p</i> = 0.003 and <i>p</i> = 0.004, respectively); 17% of the patients with ASD showed increased albumin quotients. After correction for age and gender, the group effect for total protein remained significant (<i>p</i> = 0.041) and showed a tendency for albumin quotient (<i>p</i> = 0.079). In the CSF of two ASD patients, an intrathecal synthesis of anti-glutamate decarboxylase 65 (GAD65) antibodies was found. In total, more of the ASD patients (44%) presented abnormal findings in CSF basic diagnostics compared to controls (18%; <i>p</i> = 0.013). A subgroup of the patients with adult ASD showed indication of a blood–brain barrier dysfunction, and two patients displayed an intrathecal synthesis of anti-GAD65 antibodies; thus, the role of these antibodies in patients with ASD should be further investigated. The results of the study are limited by its retrospective and open design. The group differences in blood–brain barrier markers could be influenced by a different gender distribution between ASD patients and controls. |
first_indexed | 2024-03-10T19:17:34Z |
format | Article |
id | doaj.art-0abf2eb79c88468a95c7f4e131d073b5 |
institution | Directory Open Access Journal |
issn | 2076-3425 |
language | English |
last_indexed | 2024-03-10T19:17:34Z |
publishDate | 2020-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Brain Sciences |
spelling | doaj.art-0abf2eb79c88468a95c7f4e131d073b52023-11-20T03:11:45ZengMDPI AGBrain Sciences2076-34252020-06-0110635510.3390/brainsci10060355Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum DisorderKimon Runge0Ludger Tebartz van Elst1Simon Maier2Kathrin Nickel3Dominik Denzel4Miriam Matysik5Hanna Kuzior6Tilman Robinson7Thomas Blank8Rick Dersch9Katharina Domschke10Dominique Endres11Section for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanyDepartment of Neurology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanyInstitute of Neuropathology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanyDepartment of Neurology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanyDepartment of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanySection for Experimental Neuropsychiatry, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, GermanyAutism spectrum disorder (ASD) is a common neurodevelopmental disorder characterized by difficulties with social interaction, repetitive behavior, and additional features, such as special interests. Its precise etiology is unclear. Recently, immunological mechanisms, such as maternal autoantibodies/infections, have increasingly been the subject of discussion. Cerebrospinal fluid (CSF) investigations play a decisive role in the detection of immunological processes in the brain. This study therefore retrospectively analyzed the CSF findings of adult patients with ASD. CSF basic measures (white blood cell count, total protein, albumin quotient, immunoglobulin G (IgG) index, and oligoclonal bands) and various antineuronal antibody findings of 36 adult patients with ASD, who had received lumbar puncture, were compared with an earlier described mentally healthy control group of 39 patients with idiopathic intracranial hypertension. CSF protein concentrations and albumin quotients of patients with ASD were significantly higher as compared to controls (age corrected: <i>p</i> = 0.003 and <i>p</i> = 0.004, respectively); 17% of the patients with ASD showed increased albumin quotients. After correction for age and gender, the group effect for total protein remained significant (<i>p</i> = 0.041) and showed a tendency for albumin quotient (<i>p</i> = 0.079). In the CSF of two ASD patients, an intrathecal synthesis of anti-glutamate decarboxylase 65 (GAD65) antibodies was found. In total, more of the ASD patients (44%) presented abnormal findings in CSF basic diagnostics compared to controls (18%; <i>p</i> = 0.013). A subgroup of the patients with adult ASD showed indication of a blood–brain barrier dysfunction, and two patients displayed an intrathecal synthesis of anti-GAD65 antibodies; thus, the role of these antibodies in patients with ASD should be further investigated. The results of the study are limited by its retrospective and open design. The group differences in blood–brain barrier markers could be influenced by a different gender distribution between ASD patients and controls.https://www.mdpi.com/2076-3425/10/6/355Asperger syndromeautism spectrum disorderadultscerebrospinal fluidantibodiesblood–brain barrier |
spellingShingle | Kimon Runge Ludger Tebartz van Elst Simon Maier Kathrin Nickel Dominik Denzel Miriam Matysik Hanna Kuzior Tilman Robinson Thomas Blank Rick Dersch Katharina Domschke Dominique Endres Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder Brain Sciences Asperger syndrome autism spectrum disorder adults cerebrospinal fluid antibodies blood–brain barrier |
title | Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder |
title_full | Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder |
title_fullStr | Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder |
title_full_unstemmed | Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder |
title_short | Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder |
title_sort | cerebrospinal fluid findings of 36 adult patients with autism spectrum disorder |
topic | Asperger syndrome autism spectrum disorder adults cerebrospinal fluid antibodies blood–brain barrier |
url | https://www.mdpi.com/2076-3425/10/6/355 |
work_keys_str_mv | AT kimonrunge cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT ludgertebartzvanelst cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT simonmaier cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT kathrinnickel cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT dominikdenzel cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT miriammatysik cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT hannakuzior cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT tilmanrobinson cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT thomasblank cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT rickdersch cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT katharinadomschke cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder AT dominiqueendres cerebrospinalfluidfindingsof36adultpatientswithautismspectrumdisorder |